Inhibition of synaptosomal protein synthesis by neurotransmitter substances.
D000109:Acetylcholine / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000613:Aminobutyrates / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000378:metabolism*; D002247:Carbon Isotopes; D002701:Chloramphenicol / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005971:Glutamates / Q000378:metabolism; D007930:Leucine / Q000378:metabolism; D008297:Male; D008928:Mitochondria / Q000378:metabolism; D009411:Nerve Endings / Q000378:metabolism*; D009419:Nerve Tissue Proteins / Q000096:biosynthesis*; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D013572:Synaptic Vesicles / Q000378:metabolism*; D014633:Valine / Q000378:metabolism
D000613:Aminobutyrates; D002247:Carbon Isotopes; D005971:Glutamates; D009419:Nerve Tissue Proteins; D018377:Neurotransmitter Agents; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D002701:Chloramphenicol; D000255:Adenosine Triphosphate; D003513:Cycloheximide; D010830:Physostigmine; D007930:Leucine; D014633:Valine; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine